This Article Figures Only Full Text Full Text (PDF) View Related Cardiosource Journal Scan Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (17) Citing Articles via Google Scholar Google Scholar Articles by Doyle, B. J. Articles by Holmes, D. R. Search for Related Content PubMed PubMed Citation Articles by Doyle, B. J. Articles by Holmes, D. R., Jr Related Collections Related Article

STATE-OF-THE-ART PAPER

Bleeding, Blood Transfusion, and Increased Mortality After Percutaneous Coronary Intervention

Implications for Contemporary Practice

Brendan J. Doyle, MB, BCh^_*, Charanjit S. Rihal, MD, MBA^_*, Dennis A. Gastineau, MD and David R. Holmes, Jr, MD^,_*

^_* Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota
Division of Hematology and Transfusion Medicine, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota

Manuscript received June 27, 2008; revised manuscript received December 15, 2008, accepted December 15, 2008.

^_* Reprint requests and corresponding: Dr. David R. Holmes, Jr., Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905 (Email: holmes.david{at}mayo.edu).

Advances in percutaneous coronary intervention (PCI) during the past decade have led to more widespread use of these procedures in older and sicker patients. Refinement of periprocedural antithrombotic therapy has played a particularly important role in reducing ischemic complications to very low levels in routine practice. Although the use of more powerful antiplatelet agents has been associated with increased risk of bleeding (especially among the elderly and patients with serious comorbidities), such complications have traditionally been viewed as benign in nature. Recent studies, however, have identified major bleeding after PCI as an important predictor of increased mortality. Whether this relationship between bleeding and risk of death is cause-and-effect, or merely an association based on shared risk factors, remains unclear. In this review, we examine the basis for a possible causal link between post-PCI bleeding and subsequent mortality. Possible mechanisms underpinning such a link are discussed, including a potential adverse role for blood transfusion in this setting. A framework for further clinical evaluation of this issue is presented.

Key Words: bleeding • blood transfusion • percutaneous coronary intervention

Abbreviations and Acronyms   MI = myocardial infarction   NO = nitric oxide   PAI = plasminogen activator inhibitor   PCI = percutaneous coronary intervention   RBC = red blood cell(s)   TRIM = transfusion-related immunomodulation

Related Article

Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A29. [Full Text] [PDF]

This article has been cited by other articles:

				Z. Jaffery, C. J. White, T. J. Collins, M. A. Grise, J. S. Jenkins, P. W. McMullan, R. A. Patel, J. P. Reilly, S. N. Thornton, and S. R. Ramee Factors related to a clinically silent peri-procedural drop in hemoglobin with coronary and peripheral vascular interventions Vascular Medicine, October 1, 2011; 16(5): 354 - 359. [Abstract] [PDF]

				W. T. Ball, W. Sharieff, S. S. Jolly, T. Hong, M. J. B. Kutryk, J. J. Graham, N. P. Fam, R. J. Chisholm, and A. N. Cheema Characterization of Operator Learning Curve for Transradial Coronary Interventions Circ Cardiovasc Interv, August 1, 2011; 4(4): 336 - 341. [Abstract] [Full Text] [PDF]

				R. Mehran, S. V. Rao, D. L. Bhatt, C. M. Gibson, A. Caixeta, J. Eikelboom, S. Kaul, S. D. Wiviott, V. Menon, E. Nikolsky, et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium Circulation, June 14, 2011; 123(23): 2736 - 2747. [Full Text] [PDF]

				R. Mehran, S. Pocock, E. Nikolsky, G. D. Dangas, T. Clayton, B. E. Claessen, A. Caixeta, F. Feit, S. V. Manoukian, H. White, et al. Impact of Bleeding on Mortality After Percutaneous Coronary Intervention: Results From a Patient-Level Pooled Analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events), ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy), and HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trials J. Am. Coll. Cardiol. Intv., June 1, 2011; 4(6): 654 - 664. [Abstract] [Full Text] [PDF]

				F. Bellotto, P. Palmisano, L. Compostella, N. Russo, M. Zaccaria, P. Guida, T. Setzu, A. Cati, A. Maddalozzo, S. Favale, et al. Anemia does not preclude increments in cardiac performance during a short period of intensive, exercise-based cardiac rehabilitation European Journal of Cardiovascular Prevention & Rehabilitation, April 1, 2011; 18(2): 150 - 157. [Abstract] [Full Text] [PDF]

				F. W. A. Verheugt, S. R. Steinhubl, M. Hamon, H. Darius, P. G. Steg, M. Valgimigli, S. P. Marso, S. V. Rao, A. H. Gershlick, A. M. Lincoff, et al. Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention J. Am. Coll. Cardiol. Intv., February 1, 2011; 4(2): 191 - 197. [Abstract] [Full Text] [PDF]

				D. J. Kumbhani and D. L. Bhatt Platelet activation: yet another strike against routine TRANSFUSION Eur. Heart J., November 2, 2010; 31(22): 2712 - 2714. [Full Text] [PDF]

				D. Sibbing, S. R. Steinhubl, S. Schulz, A. Schomig, and A. Kastrati Platelet Aggregation and Its Association With Stent Thrombosis and Bleeding in Clopidogrel-Treated Patients: Initial Evidence of a Therapeutic Window J. Am. Coll. Cardiol., July 20, 2010; 56(4): 317 - 318. [Full Text] [PDF]

				S. Noor, S. Meyers, and R. Curl Successful Reduction of Surgeries Secondary to Arterial Access Site Complications: A Retrospective Review at a Single Center with an Extravascular Closure Device Vascular and Endovascular Surgery, July 1, 2010; 44(5): 345 - 349. [Abstract] [PDF]

				A. P. Amin, S. P. Marso, S. V. Rao, J. Messenger, P. S. Chan, J. House, K. Kennedy, K. Robertus, D. J. Cohen, and E. M. Mahoney Cost-Effectiveness of Targeting Patients Undergoing Percutaneous Coronary Intervention for Therapy With Bivalirudin Versus Heparin Monotherapy According to Predicted Risk of Bleeding Circ Cardiovasc Qual Outcomes, July 1, 2010; 3(4): 358 - 365. [Abstract] [Full Text] [PDF]

				J. Brinker The Score Is in but Is the Decision Final? J. Am. Coll. Cardiol., June 8, 2010; 55(23): 2567 - 2569. [Full Text] [PDF]

				S. V. Rao, M. G. Cohen, D. E. Kandzari, O. F. Bertrand, and I. C. Gilchrist The Transradial Approach to Percutaneous Coronary Intervention: Historical Perspective, Current Concepts, and Future Directions J. Am. Coll. Cardiol., May 18, 2010; 55(20): 2187 - 2195. [Abstract] [Full Text] [PDF]

				K. P. Alexander and E. D. Peterson Minimizing the Risks of Anticoagulants and Platelet Inhibitors Circulation, May 4, 2010; 121(17): 1960 - 1970. [Full Text] [PDF]

				D. T. Ko, L. Yun, H. C. Wijeysundera, C. A. Jackevicius, S. V. Rao, P. C. Austin, J. F. Marquis, and J. V. Tu Incidence, Predictors, and Prognostic Implications of Hospitalization for Late Bleeding After Percutaneous Coronary Intervention for Patients Older Than 65 Years Circ Cardiovasc Interv, April 1, 2010; 3(2): 140 - 147. [Abstract] [Full Text] [PDF]

				G. W. Stone and S. J. Pocock Randomized Trials, Statistics, and Clinical Inference J. Am. Coll. Cardiol., February 2, 2010; 55(5): 428 - 431. [Abstract] [Full Text] [PDF]

				S. Massberg, J. Mehilli, and A. Kastrati Chapter 25 The role of bivalirudin in percutaneous coronary intervention Oxford Textbook of Interventional Cardiology, January 1, 2010; 1(1): med-9780199569083-chapter - med-9780199569083-chapter. [Abstract] [Full Text]